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Compared to other Western countries, malingering research is still relatively scarce in the United 
Kingdom, partly because only a few brief and easy-to-use symptom validity tests (SVTs) have 
been validated for use with British test-takers. This online study examined the validity of the 
recently introduced Inventory of Problems – 29 (IOP-29; Viglione, Giromini, & Landis, 2017) in 
the detection of feigned schizophrenia and random responding in 151 British volunteers. Each 
participant took three IOP-29 test administrations: (a) responding honestly; (b) pretending to 
suffer from schizophrenia; and (c) responding at random. Additionally, they also took the O-
LIFE questionnaire of schizotypy under standard instructions (i.e., responding honestly). The 
chief feigning scale of the IOP-29 (FDS) showed excellent validity in discriminating honest 
responding from feigned schizophrenia (AUC = .99), and its classification accuracy was not 
significantly affected by the presence of schizotypal traits. Additionally, a recently introduced 
IOP-29 scale aimed at detecting random responding (RRS) also demonstrated very promising 
results. 
Keywords: British; Feigning; Inventory of Problems; IOP-29; Malingering; O-LIFE; Online; 
Random Responding; Schizophrenia; Schizotypy; Validity.  
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Malingering is an intentional feigning or exaggeration of symptoms in order to gain 
external incentive (American Psychiatric Association, 2013). Feigning illness or disability is 
costly to society as resources are displaced away from people who are genuinely ill. Malingering 
should therefore be considered a possibility every time an individual may gain from presenting 
as impaired (Binder, 1993).  
To evaluate the possible presence of malingering, forensic assessors typically rely on 
multiple sources of information (Boone, 2013). In addition to clinical interviews and collateral 
information, psychological tests are a rich source of information which assessors can rely on in 
order to derive judgment. These tests are often grouped into two major categories: symptom 
(SVT) and performance (PVT) validity tests. The former refers to tests aimed at evaluating the 
credibility of self-reported psychological difficulties or problems, the latter refers to tests aimed 
at evaluating the credibility of scores on cognitive tests.  SVTs and PVTs, however, can only 
inform on the level of validity/credibility of a given presentation; they cannot tell whether an 
invalid/non-credible clinical presentation is feigned for an external versus internal motivation 
(van Impelen, Merckelbach, Jelicic, & Merten, 2014). As such, neither SVTs nor PVTs, per se, 
measure malingering. In line with Rogers and Bender (2013), in this article we thus refer to 
malingering to indicate the “deliberate fabrication or gross exaggeration of psychological or 
physical symptoms for the fulfilment of an external goal,” and feigning to indicate the “deliberate 
fabrication or gross exaggeration of psychological or physical symptoms (Rogers & Vitacco, 
2002) without any assumptions about its goals” (p. 518). 
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Most SVT research and resulting base rates of non-credible symptom have come from the 
United States (Martin, Schroeder, & Odland, 2015; Young, 2014, 2015). Comprehensive meta-
analyses of various forensic assessment studies point to base rates of 15±15% for malingering 
(see Young 2015), although non-credible presentations seem to occur at higher base rates, 
possibly around 40% (Larrabee, 2003), in neuropsychological assessment (see Young, 2014), 
and at an even higher than 50% base rate in medico-legal disability claimants and forensic 
criminal cases, especially if validated screens such as the Miller Forensic Assessment of 
Symptoms Test (M-FAST; Miller, 2001) are used (Rogers & Bender, 2018). Less is known 
concerning base rates of malingering and non-credible symptom reporting in the UK, as there is 
not widespread use of the psychological tests (McCarter, Walton, Brooks, & Powell, 2009), and 
this is in large part due to the division of medical and legal systems of care (Halligan, Bass, & 
Oakley, 2003). More specifically, the UK substantially lacks symptom validity assessment 
research (Merten et al., 2013), which notably limits the possibility to investigate malingering-
related phenomena within this cultural context.  
Symptom Validity Assessment in the UK 
While SVTs are very commonly used in the US, a less stringent approach is taken in the 
UK, in large part due to British Psychological Society (BPS) caution against using these 
instruments (McMillan et al., 2009), especially when there is initially no forensic context for 
treatment. As the UK approaches mental healthcare treatment and forensic rehabilitation in 
highly centralized systems, use of SVTs in clinical clients within a medico-legal context (e.g., 
claimants) is a grey area fraught with potential systemic complications.  
 In a review of symptom validity practices in European countries, Merten and colleagues 
(2013) note a paucity of SVT research in Great Britain, specifically a lack of litigant studies, a 
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lack of studies evaluating chronic pain, and a lack of studies in the context of criminal forensic 
neuropsychological assessments. This is reflected in UK clinical practice as "few psychologists 
[provide] these specialist assessments" (p. 135). In a review of both academic and government 
statistics, there is a scarcity of information concerning base rates of cognitive impairment 
(McMillan et al., 2009), suspected rates of feigning of specific disorders, and fraudulent medico-
legal claims in the UK. One of the biggest issues concerning SVT research in the UK is a general 
lack of reported base rates for non-credible responding, however there is no data suggesting UK 
rates would be dramatically different from those reported in the US, and there is certainly not 
reason to believe rates of non-credible responding would be lower in the UK. For medico-legal 
disability claimants and forensic criminal cases, the BPS points to the US as a guide for base 
rates of malingering (McMillan et al., 2009), at approximately 54 to 72% (see Miller, Ryan,  
Carruthers, & Cluff, 2004; Chafetz, 2008), and approximately 54% respectively (see Ardolf, 
Denney, & Houston, 2007). 
In a self-selected survey of 91 British neuropsychologists practicing in medico-legal 
clinical cases (McCarter et al., 2009), only 7% reported they viewed SVTs as mandatory, and 
only 13% of them reported using SVTs most of the time (>95%). Top reported reasons for not 
using SVTs included: invalidity is obvious in presentation (38%), invalidity is obvious in (other) 
test scores (38%), insufficient time (35%), and the belief that few patients exaggerate (34%). An 
outdated reliance on clinical intuition and the belief that most clients were genuine was largely 
regarded as the reason that most of these experts did not use SVTs, and the authors 
acknowledged that this finding, in conjunction with varying approaches, frequency of use, and 
measures, was likely to significantly bias attempts to report base rates of malingering. Currently, 
practitioner and community-based whistleblowing via the NHS Counter Fraud Authority serves 
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as the main system for combating patient abuse of services (Department of Health & Social Care, 
2020). 
 Despite the paucity of information concerning base rates of non-credible responding, 
fraudulent medico-legal claims are becoming an increasing issue in the UK (McCarter et al., 
2009). The UK Department for Work and Pensions (2019) reported overpaying £4.1 billion in 
welfare benefits in 2018-2019, as fraudulent overpayments have jointly been awarded at the 
highest estimated level (1.2%) steadily since 2016-2017. The UK Disability Unit (2020) offers 
several financial benefits for individuals affected by long term (i.e., if it is likely to last 12 
months) mental health problems, and schizophrenia is listed one of these stated conditions. To 
promote research in this area, it would be beneficial to validate brief and easy-to-use SVT like 
the Inventory of Problems – 29 (IOP-29; Viglione & Giromini, 2020; Viglione, Giromini, & 
Landis, 2017) for use with a British population. 
Schizophrenia and Schizotypy 
Schizophrenia and its associated symptoms are among the more commonly feigned 
psychiatric complaints in criminal forensic contexts (see Pierre, Shnayder, Wirshing, & 
Wirshing, 2004). According to the World Health Organization classification (WHO, 2008) 
schizophrenia is one of the most severe disabilities. The DSM-5 considers schizophrenia as a 
spectrum disorder, which includes delusions, hallucinations, and/or disorganized speech, and can 
also include grossly disorganized behavior, catatonic behavior, or negative symptoms.  Similarly, 
the ICD-11 contains a section on Schizophrenia and other primary psychotic disorders, which are 
characterized by significant impairments in reality testing and alterations in behavior. These 
symptoms manifest as positive symptoms (i.e., changes in behavior or thoughts), such as 
persistent delusions, persistent hallucinations, disorganized thinking (typically manifest as 
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disorganized speech), grossly disorganized behavior, experiences of passivity and control, and 
negative symptoms (i.e., withdrawal or lack of function), such as blunted or flat affect, avolition, 
and psychomotor disturbances (WHO, 2018).   
Schizotypy is a psychological construct that is intimately connected to latent 
schizophrenia-related liability and symptomatology (Meehl, 1962; Meehl, 1994; Lezenweger, 
2006; Rado, 1960). Over the years there has been a debate over the measure of schizotypic 
psychopathology, and to what extent schizotypy is helpful in determining risk of the 
development of schizophrenia or psychotic-related disorders (Grant et al., 2013; Lenzenweger, 
2015). The DSM-5 describes Schizotypal Personality Disorder (STPD) as a "pervasive pattern of 
social and interpersonal deficits marked by acute discomfort with, and reduced capacity for, 
close relationships as well as by cognitive or perceptual distortions and eccentricities of 
behavior, beginning by early adulthood and present in a variety of contexts" (APA, 2013, p. 
655). In contrast, the ICD-11 does not include STPD as a diagnosis, as its features are coded 
within Schizophrenia and other primary psychotic disorders. Instead, the ICD-11 classifies 
Personality Disorder severity in terms of whether the patient experiences "dissociative states or 
psychotic-like beliefs or perceptions" and its diagnostic approach is conceptualized by the 
capacity for reality testing (WHO, 2018). Schizotypy as a dynamic and latent pathological 
construct is more closely aligned with the ICD-11's conceptualization of its features (i.e., unusual 
experiences), in which they serve to moderate a given diagnosis of either Schizophrenia or a 
Personality Disorder, as opposed to being defined as a standalone diagnosis (STPD) in the DSM-
5 (Kirchner, Roeh, Nolden, & Hasan, 2018). Broadly speaking, psychotic disorders can be 
conceptualized as a spectrum with schizotypy at the less severe end and schizophrenia at the 
more severe end (Claridge & Beech, 1995). There is a growing body of evidence that suggests 
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schizotypy shares a common biological basis with schizophrenia as defined by both genetic 
susceptibility and pathological processes related to dopamine dysregulation (Avramopoulos et 
al., 2002; Grant et al., 2013; Lachman et al., 1996; Smyrnis et al., 2007; Vandenbergh et al., 
1992).  
The Inventory of Problems – 29 (IOP-29) 
To assist practitioners in evaluating the credibility of psychological and cognitive 
disorder presentations, a particularly promising tool was introduced in 2017. Comprised of only 
29 self-administered items and named the “Inventory of Problems – 29” (IOP–29; Viglione & 
Giromini, 2020; Viglione, Giromini, & Landis, 2017), it differs from most SVTs in five ways:  
1) It focuses on the manner in which purported symptoms are presented, as opposed to 
the presence or absence of atypical versus bona fide symptoms.  
2) It intermixes self-report and cognitive (e.g., calculation, logic) items, so it is applicable 
for both psychiatric and cognitive complaints. 
3) In addition to the typical “True” and “False” response options, self-report items also 
offer a third option: “Doesn’t make sense”, allowing the test-taker to indicate that the 
question is unanswerable or awkwardly stated. This trichotomous response choice also 
allows each item to be scored positively or negatively for more than one response choice.  
4) The IOP-29 does not use a T-score metric based on a single set of normative reference 
data obtained from healthy volunteers. Instead, the IOP-29 standardized score used for 
interpretation, the False Disorder Probability Score (FDS) is based on the comparison of 
the test-taker’s responses against two different sets of reference values, one coming from 
bona fide patients, and the other one coming from experimental simulators. A logistic 
regression-derived formula generates the False Disorder Probability Score which 
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establishes the statistical probability that a given IOP-29 comes from valid versus invalid 
symptom presentation. Greater FDS scores are associated with non-credible presentations 
and lower scores are associated with credible presentations. As a probability score it 
ranges from zero to one. Without a priori expectation, the FDS cut-off score is ≥ .50.  
5) Indeed, the fifth critical distinction between the IOP-29 and typical SVTs is that this 
cut-off has been stable across schizophrenia and psychosis, depression, PTSD, and mild 
cognitive disorders in all the research on the text as summarized in the test manual 
(Viglione & Giromini, 2020).  
Viglione et al.’s (2017) initial clinical comparison simulation studies conducted in the US 
(which compared experimental feigners to bona fide patients) showed that the IOP-29's 
classification accuracy was similar to that of other symptom validity measures, including the 
MMPI-2 and PAI validity scales, with sensitivity and specificity values of about .80 for FDS 
≥ .50. Further, an Italian clinical comparison study demonstrated that the IOP-29 outperformed 
the Structured Inventory of Malingered Symptomatology (SIMS; Smith & Burger, 1997; 
Widows & Smith, 2005), with the greatest effect sizes (patients versus experimental feigners) 
between the two tests found in psychotic spectrum disorders-related presentations (d (IOP-29) 
= 1.80 vs. d(SIMS) = 1.06; AUC(IOP-29) = .89 vs. AUC(SIMS) = .79). More recently, studies 
conducted in Portugal (Giromini, Barbosa et al., 2019) and Italy (Giromini, Carfora Lettieri et 
al., 2019) showed that the IOP-29 yielded incremental validity over the Test of Memory 
Malingering (TOMM; Tombaugh, 1996) and Minnesota Multiphasic Personality Inventory 
(MMPI-2; Butcher et al., 1989, 2001), respectively. Additionally, the cross-cultural adaptability 
of the IOP-29 has been recently demonstrated also in Lithuania (Ilgunaite, Giromini, Bosi, 
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Viglione, & Zennaro, 2020). To our knowledge, however, no study has yet examined the validity 
of the IOP-29 FDS with a British population. 
Random Responding 
 Like other SVTs, the IOP-29 may be susceptible to the effects of random or inattentive 
responding, which might occur either because a test taker did not understand the meaning of the 
items or because they somehow did not cooperate with the testing situation. Random responding 
and malingering are both considered to be invalid response styles, and both response styles may 
at times produce overstated pathology and suboptimal performance on cognitive items and/or 
neuropsychological tests (Rogers, 2008). However, unlike malingering, random responding is 
not characterized by deception or an intention to deceive the examiner. Instead, it involves 
responding without paying proper attention or without really understanding the meaning of the 
item(s) (Nichols, Greene, & Schmolck, 1989). Alternatively, it also might arise from resistance 
to the testing in the form a purposeful attempt to avoid disclosing information to the examiner.  
Partial resistance might emerge in the form of discontinuing effort and cooperation after initially 
attempting to answer questions honestly. When an SVT includes items describing rare symptoms 
or unlikely behaviors and attitudes, a bona fide responder may inadvertently endorse these items, 
as pathological individuals are more likely than non-pathological individuals to endorse rare 
complaints on these types of tests (Greiffenstein & Baker, 2008; Rogers & Bender, 2018; Slick, 
Sherman, Grant, & Iverson, 1999). Consequently, if the response-pattern appears random-like, 
test scales which address overreporting of symptoms and problems may be artificially inflated 
(Burchett et al., 2016). 
Both overreporting and random responding can co-occur and interact, and they can both 
involve “inconsistent” and “infrequent” responding (e.g., Morey, 1991). Inconsistent responding 
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is endorsing contradictory items whereas infrequent responding is choosing response options 
which are rarely selected by others. Practitioners, however, should try to discriminate whether a 
non-credible symptom presentation is caused by random responding versus feigning. As such, 
the inclusion of embedded measures of task engagement within SVTs are one way to help 
clinicians discriminate different types of non-credible response styles. To that goal, Giromini, 
Viglione et al. (2019b) have recently derived the IOP-29 Random Responding Scale (RRS), an 
IOP-29 index aimed at detecting random responding. In their developmental research, the IOP-
29 RRS yielded promising results. However, no study has yet cross-validated Giromini, Viglione 
et al.’s (2019b) findings.   
Current Study 
The current study sought to evaluate the applicability of the IOP-29 to a British 
population, and to provide initial cross-validation data to evaluate the potential utility of the IOP-
29 FDS and RRS. Additionally, we aimed at testing the extent to which the presence of 
schizotypal traits would influence IOP-29 FDS scores. More specifically, because clinical test-
takers are known to score higher on SVTs than healthy test-takers do (Rogers & Bender, 2018; 
van Impelen et al., 2014), we intended to evaluate the extent to which individuals with higher 
schizotypal traits would score higher on the IOP-29 when answering honestly. Besides, we also 
wanted to explore whether specific schizotypal traits could influence one’s ability to effectively 
feign schizophrenia without being detected by the IOP-29. Briefly stated, we wanted to evaluate 
whether greater levels of schizotypal traits could increase the likelihood of obtaining false 
negative and false positive classifications on the IOP-29.     
We conducted an online study with a community sample, resembling the procedures 
followed by Giromini, Viglione, et al. (2019a) when testing the applicability of the IOP-29 FDS 
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to various symptom presentations. Participants took the IOP-29 three times, in three different 
conditions. In the honest condition (HON), they were instructed to respond honestly following 
standard instructions; in the simulation or feigning condition (SIM) they were coached to 
simulate schizophrenia; and in the random responding condition (RND) they were asked to 
respond randomly, with no apparent pattern to their responding.  Additionally, all participants 
also took a brief measure of schizotypal traits under standard instructions, i.e., with the request to 
respond honestly.  
We hypothesized that: 1) SIM condition would yield significantly greater FDS scores 
than HON, with large effect sizes; 2) individuals with higher schizotypal traits would score 
higher on FDS in condition HON in comparison to individuals with low schizotypal traits (as 
they are expected to show higher inconsistency in their responses) and perhaps lower on FDS in 
condition SIM (due to the overlapping symptomatology with schizophrenia itself); 3) RND 
condition would yield significantly higher RRS scores than both HON and SIM conditions, with 
no significant differences in RRS scores between HON and SIM.  
Method 
Participants  
A British community sample made up of 151 adult volunteers (74.17% women), ranging 
in age from 18 to 59 (M = 25.79, SD = 9.33) participated in this online study. In terms of 
education, a little less than half of the sample (n = 67; 44.37%) completed high school (A-levels) 
or less, 28.48% completed an undergraduate degree (n = 43), 25.83% completed a postgraduate 
degree or more (n = 39), and two individuals endorsed the response option “Other.” Most of the 
sample (98.68%) spoke English as their native language (two were native in Russian). Inclusion 
criteria required literacy and the ability to provide informed consent. Participants who reported 
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using intoxicating substances (i.e., alcohol, drugs) that day were excluded from participating. 
Further criteria which prevented full participation included: experiencing visual or audio 
hallucinations in the last 30 days; being treated for substance abuse problems, a neurological 
disorder, or traumatic brain injury in the past six months; and any historical diagnosis of 
psychosis, schizophrenia, bipolar disorder, or schizoaffective disorder.  
Prior to reaching the final sample size (N = 151), approximately 30 individuals were 
excluded from participating; and this was primarily due to admission of recent (<30 days) 
hallucinations, secondarily due to recent (<1 day) intoxicant use, and tertiarily due to incorrectly 
responding to control question (i.e., manipulation check; see below) which determined that the 
participant was not reading the administration instructions.  
Materials 
The Inventory of Problems-29 (IOP-29; Viglione & Giromini, 2020). The IOP-29 is a 
29 item, self-administered test designed to evaluate the credibility of various clinical 
presentations. It includes 27 items with three response options: True/False/Doesn't make sense. 
Among them are 26 self -report items about emotional, ideational, social, or personal experiences 
and a verbal reasoning item in the form of an analogy. The test also includes two open-ended 
questions which require mathematical reasoning and calculations. For the purpose of this study, 
the test was administered three times, in which the test taker was asked to respond honestly 
(HON), randomly (RND), and experimentally feigning schizophrenia (SIM). FDS and RRS 
scores were generated for each participant in each test taking condition. 
The Oxford-Liverpool Inventory of Feelings and Experiences: Short scale for 
measuring schizotypy (Mason & Claridge, 2006). The O-LIFE short scale is a 43-item self-
administered test, which reliably measures multi-dimensional schizotypy. The measure is based 
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on Claridge's (1997) conceptualization of schizotypy as fully-dimensional, suggesting intra-
individually static basis of personality-based traits, whereby (despite an absence of cut-off 
scores), high values suggest an increased risk of developing psychotic disorder. The O-LIFE 
short scale quantifies the endorsement (i.e., "Yes/No") of items loaded onto the following 
subscales (reported α in this sample): Unusual Experiences (α = .75), Cognitive Disorganization 
(α = .78), Impulsive Nonconformity (α = .62), and Introvertive Anhedonia (α = .68).   
The O-LIFE was administered once, at the end of the study, and participants were asked 
to report honestly. It was included to evaluate whether individuals with higher schizotypal traits 
would be more likely to generate false positive and false negative classifications on the IOP-29, 
as noted above. In addition, because STPD and schizophrenia share a common biological basis, 
we were interested in exploring the associations between specific schizotypal traits and FDS 
response styles.   
Procedure 
Ethical approval was obtained from the relevant institutional review board. The first 
author advertised the online study via a UK university SONA research participation system and 
social media groups for UK-based research participation. Further, the authors encouraged 
snowball sampling, as they emailed the shareable study link with UK-based researchers.  
Participants were informed of the nature of the study before participating, and that they would be 
asked to take the same questionnaire three times - once, responding honestly, once responding 
randomly, and once responding as if they had schizophrenia. Participants were asked to not 
participate if they might be uncomfortable disclosing their mental health or substance use 
history. Participants received an information form and provided their electronic informed consent 
via Qualtrics.  
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First participants were asked demographic questions, including their highest level of 
acquired education (or equivalent) within the British system (GCSE's/O-level, A-levels, 
undergraduate degree, postgraduate degree, and other). They were then asked about their recent 
substance use and historical mental health issues. Participants were then instructed to take the 
same questionnaire three times, in three different ways - responding honestly, responding 
randomly, and responding as if they are faking schizophrenia. The order of the administration of 
the three different testing conditions was randomized across participants. In the standard 
instructions for responding honestly, participants were told to "respond honestly - that is, how 
[they felt] today - not faking, and not role playing." In the random responding instructions, 
participants were asked to respond "randomly, with no pattern."  In the faking schizophrenia 
instructions, participants were asked to "respond as if you are faking schizophrenia (but without 
'over-exaggerating' your presentation, not to look like a feigner)." As part of instructions for the 
faking condition, participants were provided with short scenario to read (see Appendix A) about 
a character who wishes to fake schizophrenia, and they were told to imagine themselves as that 
individual. The character in the story is motivated to fake a presentation of schizophrenia in 
order to mitigate impending financial hardship. The vignette included a link to the UK's National 
Health Service website on schizophrenia, and participants were encouraged to read about its 
symptoms.  To incentivize participants to fake schizophrenia well, it was emphasized that the 
best three fakers who can "trick the psychologist into thinking [they] have schizophrenia," would 
win one of three £20 (~$30 USD) cash prizes.  
After reading response instructions and immediately preceding the beginning of each 
IOP-29 test administration, participants were asked the following control question (manipulation 
check): "How should you answer the following 29 questions?" to ensure that they understood 
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how they were expected to respond (honestly, randomly, or faking schizophrenia). If a 
participant responded incorrectly to this control question in any condition, the study 
automatically ended, and their data were not analyzed (that is, all 151 participants included in the 
analyses responded accurately to the control questions).  
At the end of the three IOP-29 administrations, participants were asked to honestly 
complete a questionnaire about their own thoughts, feelings, experiences, preferences (O-LIFE, 
short version). Data downloaded from Qualtrics and imported to SPSS and excel for use in R. 
De-identified participant IOP-29 data was imported to www.iop-test.com. 
While we initially aimed to exclude participants from analysis who did not take at least 
10 seconds to read the vignette, (as we expected that they would not take the study seriously), we 
decided to include these cases (n = 11) in analyses after examining the data for two reasons. 
First, many of these specific individuals were psychology students, and therefore it is possible 
that they may have skipped reading the vignette because they thought they had a good 
understanding of schizophrenia. Second, because post-hoc analyses revealed that including or 
excluding those 11 individuals would lead to virtually identical results.   
Data Analysis 
For the FDS, we only investigated the honest (HON) and simulated (SIM) conditions, as 
the FDS was designed to discriminate honest (credible) from feigned (non-credible) 
presentations. For the RRS, we inspected all three conditions, i.e., HON, SIM, and random 
(RND), as the RRS was designed to discriminate random responding from both honest and 
feigned responding. For FDS, we first report the results of a series of linear mixed effects 
models, conducted using the lme4 package in R (Bates, Mächler, Bolker, & Walker, 2015)1. 
                                                          
1 For access to the code, please contact author Lara Warmelink at l.warmelink@lancaster.ac.uk 
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Simple models were built first, starting with adding the effect of condition, then adding O-LIFE 
scores, and then adding the effect of education. Where a newly added variable led to a significant 
improvement in the model, interaction effects were also tested. All models included a random 
effect of participant, to account for the repeated measures nature of the data. Models were 
compared using the ANOVA function. Graphs were extracted using the effects package (Fox & 
Weisberg, 2019). For RRS, we only used a linear mixed effect model to look at the effect of 
condition.  
For both FDS and RRS, we then report Cohen’s d, receiver operator characteristic curve 
(AUC), sensitivity, and specificity. With regard to Cohen’s d effect size, in line with Dunlap, 
Cortina, Vaslow, and Burke’s (1996) recommendations, we calculated it using standard 
independent samples d formula (1988) rather than Morris and DeShon’s (2002) corrected value, 
as we were interested in calculating the actual effect size as opposed to an a priori power 
calculation. Lastly, because the IOP-29 RRS was designed to measure random responding while 
remaining independent from the IOP-29 FDS, the correlation between these two IOP-29 indexes 
was tested too.  
Results 
Effectiveness of the IOP-29 FDS 
Descriptive statistics for all IOP-29 and O-LIFE scores included in the analyses are 
presented in Table 1. With regard to the effectiveness of the IOP-29 FDS, there was a significant 
main effect of condition in the first model, estimate = 0.67, SE = 0.02, t = 38.47. The scores of 
the IOP-29 FDS were indeed remarkably higher in condition SIM (M = .82; SD = .18) than in 
condition HON (M = .14; SD = .14), with a very large Cohen’s d of 4.20 (see also Figure 1). 
Adding the four subscales of the O-LIFE (Unusual Experiences, Cognitive Disorganization, 
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Introvertive Anhedonia and Impulsive Nonconformity) was a significant improvement in the 
model, Chi2 (4)=  29.42, p = 0.000006 (Table 2). However, only Introvertive Anhedonia was a 
significant predictor (Table 3). A model with only Introvertive Anhedonia was not significantly 
different from a model with all O-LIFE subscales, Chi2 (3) = 2.72, p = 0.44. Therefore, only 
Introvertive Anhedonia was taken forward into more complex models.  
Adding an interaction between condition and Introvertive Anhedonia did not improve the 
model over just including the main effects, Chi2 (1) = 2.58, p = 0.11 (Table 2). Since Introvertive 
Anhedonia is a positive predictor of FDS, this may lead to concern that the FDS is less accurate 
in people with high Introvertive Anhedonia. However, there is no evidence to suggest this. 
Figure 2 contains the non-significant interaction effect between condition and Introvertive 
Anhedonia. It shows that FDS scores in the HON and SIM conditions lie on different sides of the 
standard FDS = 0.50 cut-off regardless of the Introvertive Anhedonia score. To confirm that O-
LIFE scores did not significantly affect FDS, we ran a model predicting the accuracy of each 
participant’s classification (as HON and SIM) by using their score on each of the four O-LIFE 
subscales, and a random effect of participant as predictors. A model that simply predicted 
classification accuracy based on the random effect of participant only performed equally well, 
Chi2 (4) = 6.69, p = 0.15. Similarly, none of the O-LIFE subscales were significant predictors of 
classification accuracy in this model (all z < 1.90, all p > 0.05).  
There is no evidence that education influenced FDS scores. As noted above, two 
individuals endorsed “Other” for the education field. They were treated as missing in these 
analyses, so that a direct comparison between a model with and without education is not 
possible. However, a model including condition, Introvertive Anhedonia and education showed 
no significant effect of education, estimate = -0.003, SE = 0.01, t = -0.27.  
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Table 4 provides some additional information on the classification accuracy of the IOP-
29 FDS by inspecting a conservative (IOP-29 FDS ≥ .65), standard (IOP-29 FDS ≥ .50), liberal 
(IOP-29 FDS ≥ .30) and very liberal (IOP-29 FDS ≥ .15) cut-off score (Giromini et al., 2018). 
Specificity ranged from 71.5 (for IOP-29 FDS ≥ .15) to 99.3 (for IOP-29 FDS ≥ .65); sensitivity 
ranged from 82.8 (for IOP-29 FDS ≥ .65) to 100 (for IOP-29 FDS ≥ .15).  
Effectiveness of the IOP-29 RRS 
We next focused on the effectiveness of the IOP-29 RRS in the detection of random 
responding. Again, we found a strong effect of condition in the first model (HON v. RND 
estimate = 19.05, SE = 0.91, t = 20.98; HON v. SIM estimate = 3.17, SE = 0.91, t = 3.50). The 
highest IOP-29 RRS scores were produced by RND (M = 68.4; SD = 9.2), followed by SIM (M = 
52.5; SD = 8.9), and lastly by HON (M = 49.3; SD = 6.5). The size of the difference between 
RND and the other two conditions was d = 2.40 for HON and d = 1.76 for SIM; the difference 
between HON and SIM consisted of a much smaller d of .41. A graphical representation of the 
IOP-29 RRS scores obtained across the three conditions is reported in Figure 3. 
By using the cut-off score of T ≥ 61 as recommended by Giromini, Viglione, et al. 
(2019b), we inspected the classification accuracy of the IOP-29 RRS across the three conditions. 
The results of these analyses, reported in Table 5, produce specificity values ranging from 84.1% 
(condition SIM) to 96.7% (condition HON), and sensitivity of 83.4% (condition RND). AUC 
values were .95 (SE = .02), .90 (SE = .02), and .92 (SE = .02) respectively, when comparing 
condition RND versus condition HON, versus condition SIM, and versus conditions HON and 
SIM combined (Figure 4). 
The correlation of IOP-29 RRS to IOP-29 FDS was .34 in condition HON, -.27 in 
condition SIM, and .22 in condition RND (all of these correlations were statistically significant 
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at p < .01). Unexpectedly, thus, the scores of the IOP-29 RRS were not independent from those 
of the IOP-29 FDS. Interestingly, in conditions HON and RND the two indexes correlated 
positively, whereas in condition SIM they correlated negatively. 
Discussion 
The current study was designed to test the validity of the Inventory of Problems-29 (IOP-
29; Viglione & Giromini, 2020; Viglione et al., 2017) with a British population. Additionally, it 
also provided a first independent validation of the IOP-29 Random Responding Scale (RRS; 
Giromini, Viglione, et al., 2019b). Examination of 453 IOP-29 protocols from 151 adult 
volunteers revealed that: 1) the False Disorder Probability Score (FDS) of the IOP-29 
discriminated feigned schizophrenia from honest responding with excellent accuracy in this UK 
sample; 2) the IOP-29 RRS accurately differentiated random responding from both feigned 
schizophrenia and honest responding.  
When comparing the IOP-29 FDS values in the honest versus feigning schizophrenia 
conditions our Cohen’s d was 4.20 and AUC was .99. We thus may conclude that the 
performance of the IOP-29 FDS with our British sample was at least as good as it was in 
Giromini, Viglione, et al.’s (2019a) study conducted with Italian healthy volunteers (where 
Cohen’s d was 3.16 and AUC was .96 in the schizophrenia-related condition). However, 
simulation/analogue studies yield larger effect sizes when comparing experimental feigners 
against nonclinical controls rather than against bona fide patients (Rogers & Bender, 2018; van 
Impelen et al., 2014). Indeed, Viglione et al.’s (2017) studies conducted in the US included a 
subsample of 45 bona fide psychosis patients and 45 healthy schizophrenia feigners and found a 
lower Cohen’s d value of 1.95, and a smaller AUC of .92. Along the same lines, Giromini et al. 
(2018) found a Cohen’s d of 1.80 and a AUC of .89 in a large Italian sample (N = 452) when 
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comparing a subsample of 89 bona fide patients affected by psychosis to 125 schizophrenia 
feigners. Thus, future replications with clinical control samples are sorely needed. Nevertheless, 
it is noteworthy that the average IOP-29 FDS values found in the SIM condition of our study (M 
= .82; SD = .18) closely resemble those observed in other International experimental simulator 
samples. For instance, in Giromini, Viglione, et al.’s (2019a) Italian study (N = 400) the average 
IOP-29 FDS value for simulators was .82 (SD = .20); in Giromini, Barbosa, et al.’s (2019) 
Portuguese study (N = 100) simulators scored on average .82 (SD = .20); in Ilgunaite et al.’s 
(2020) Lithuanian study simulators produced an average IOP-29 FDS of .77 (SD = .18). 
Our analyses also indicated that the presence of schizotypal traits did not notably 
influence the IOP-29’s accuracy. Indeed, although participants with high Introvertive Anhedonia 
tended to generate slightly inflated FDS scores in both HON and SIM conditions, using the 
standard cut-off score of IOP-29 FDS ≥ .50 ensured the same classification accuracy regardless 
of what their score on Introvertive Anhedonia was. This finding and the consistency noted of the 
FDS noted in the above paragraph supports using the standard, IOP-29 FDS cut-score of .50 
whenever applicable. It is important to acknowledge, however, that assessors using more liberal 
FDS cut-off scores such as IOP-29 FDS ≥ .30 might run a slightly increased risk of falsely 
classifying individuals with high Introvertive Anhedonia as feigners. As those lower cut-off 
scores are typically used for screening purposes, we recommend that when setting these cut-offs, 
subsequent, follow-up testing would include a measure of schizotypy-related traits, if possible.   
Another encouraging finding is that the IOP-29 RRS discriminated IOP-29s in the RND 
condition from those in the HON and SIM conditions (AUC ≥ .90). Giromini, Viglione et al. 
(2019b) developed the IOP-29 RRS with the purpose of identifying content unrelated distortions, 
associated for example with impaired cognitive or reading abilities or uncooperative responding. 
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The ultimate goal was to identify possible IOP-29 FDS false positive outcomes originated by 
poor comprehension of the items, distraction, resistance to the testing, and random responding 
rather than active feigning. Because we instructed our participants to respond completely at 
random, however, additional research is needed to address whether the RRS also performs 
adequately with partial random responding or reduced attention/concentration.  
One last consideration deserves mentioning, with regard to the relationship between the 
FDS and RRS. When Giromini, Viglione et al. (2019b) developed the RRS, their goal was to pull 
apart content-related (e.g., voluntary exaggeration or malingering) from content-unrelated (e.g., 
random responding, unable to understand the questions, resistance) distortion sources. As such, 
we did not expect the RRS values to be directly associated with those of the FDS. Instead, in our 
study the RRS and FDS correlated positively in the HON condition and negatively in the SIM 
condition. A possible explanation for this finding is that the RRS might moderate the validity of 
the FDS. Indeed, in the HON condition, where the FDS was supposed to be low, the presence of 
some randomness in the responses tended to artificially inflate the FDS values. Conversely, in 
the SIM condition, where the FDS was supposed to be high, the presence of some randomness in 
the responses tended to artificially diminish the FDS values. That is, the more the participant 
understood and put an effort into completing the IOP-29 with the needed attention per 
administration instruction, the more accurate their FDS. If these speculations were true, the RRS 
might prove particularly helpful in those cases in which the FDS is close to .50, i.e., the ‘too-
close-to-classify’ cases (Rogers & Bender, 2018). In those situations, if the FDS is moderately 
high, there are two likely possibilities: The person is exaggerating/feigning, or they 
misunderstood/lacked attention to the test items. To determine whether a marginally high FDS 
scorer misunderstood/lacked attention to the test items, we should examine the RRS. If the 
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corresponding RRS is high, it is possible that the person did not understand the test or did not 
cooperate with it, whereas if RRS is low, it is more likely that the person simply exaggerated 
their symptoms. When both FDS and RRS are low, this increases the likelihood that a test taker 
is responding in a valid manner, as scoring low on both of these scales require meticulous 
attention to the test content. Additional research – particularly with clinical samples – is needed, 
however, so these recommendations should be considered to be largely speculative, at this point. 
Our study has some important practical limitations. First, the ecological conditions and 
motivations that prevail in real-life malingering or random responding cannot be imposed in an 
online study. Thus, the external validity of our study is limited, especially when one visualizes 
that many participants likely completed their testing at their leisure in the comfort of their home. 
Secondly, our quasi-experimental design was vulnerable to confounds as participant compliance 
with instruction at each administration was unknown. Respondent noncompliance is an ongoing 
threat to validity in malingering studies (Rai, An, Charles, Ali, & Erdodi, 2019; Walls, Wallace, 
Brothers, & Berry, 2017), as these studies operate on the assumption that test outcomes are 
primarily linked to the absence or presence of motivation, as opposed to commitment to 
instructions (see An, Charles, Ali, Enache, Dhuga, & Erdodi, 2019). Although our study used a 
manipulation check to exclude respondents who were not attentive to instructions, future studies 
should employ a more rigorous manipulation check. On the other hand, such internal validity 
problems would reduce rather than inflate effect sizes. Third, our use of one vignette in which 
the character is motivated to feign psychosis for external gain may have limited our ability to 
evaluate the impact of vignette-specific characteristics. Future studies should examine different 
scenarios within vignettes (Giromini, Viglione et al., 2019a), and additionally use vignettes in 
which characters are motivated to feign in order to mitigate criminal culpability and punishment. 
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Fourth, while random responding in the study was instructed as "respond randomly - that is, with 
no apparent pattern," we did not enquire about the strategies individuals used to respond 
randomly and thus, we could not determine whether specific strategies impacted the RRS. Future 
studies should identify and investigate specific styles of random responding (e.g., reading 
difficulties, distractibility, and resistance) as they relate to honest and feigned responding. Fifth, 
our administration did not allow test takers to skip responses, which may be common in both 
feigning and random responding. Sixth, although we excluded individuals with certain 
psychiatric problems from participating (<6 months: neurological, TBI, substance use; lifetime 
history: psychosis-related disorders) it is unclear how or whether our inclusion of individuals 
with psychiatric diagnoses such as depression, anxiety, and learning disorders may have affected 
the findings. Despite this, the inclusion of individuals with less severe pathological issues may 
have served to represent an accurate real-world sample, in that feigners may be suffering 
psychological problems which are not related to their presenting complaint. Finally, 
generalizability of our findings is limited due to absence of a clinical comparison group. Future 
clinical comparison samples might differentiate FDS and RRS values in non-pathological 
controls versus individuals who already suffer one or more specific psychiatric complaints, or 
possibly test the ecological validity of the IOP-29 with a ‘real-life’ forensic sample as was 
recently done by Roma et al. (2020).  
Despite the limitations, this study adds to the growing literature on the applicability and 
utility of the IOP-29. This is the first use of the IOP-29 with a British sample, further 
strengthening its cross-cultural generalizability. Our study also supports the notion that even if 
schizotypic test takers might score slightly higher than controls on the FDS scale, they should not 
do so at a level that might notably interfere with the IOP-29’s classification accuracy. Finally, 
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this is the first IOP-29 study to independently cross-validate the psychometric properties of the 
IOP-29 RRS, providing preliminary but encouraging evidence in support of its possible 
applicability to real-life contexts.   
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HON 0.14 0.14 
 




HON 49.3 6.5 
 
SIM 52.5 8.9 
 




Unusual Experiences 2.75 2.48 
 
Cognitive Disorganization 5.66 3.01 
 
Introvertive Anhedonia 2.70 2.24 
 
Impulsive Nonconformity 3.44 2.15 
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Table 2. Linear Mixed Effects Models Testing the Effectiveness of the IOP-29 FDS  
Model NPAR AIC BIC Loglikelihood Deviance 
Condition only 4 -243.99 -229.15 125.99 -251.99 
Condition + all O-LIFE subscales 8 -265.40 -235.72 140.70 -281.40 
Condition + Introvertive Anhedonia 5 -268.68 -250.13 139.34 -278.68 
Condition * Introvertive Anhedonia 6 -269.26 -247.00 140.63 -281.26 
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Table 3. Predictors Included in the Linear Mixed Effects Model Testing the Effect of O-LIFE 
subscales on the IOP-29 FDS 
 Estimate SE t 
(Intercept) 0.11 0.02 4.80 
Condition SIM 0.67 0.02 38.47 
Cognitive Disorganization 0.00 0.00 -0.59 
Introvertive Anhedonia 0.02 0.00 5.25 
Impulsive Nonconformity -0.01 0.01 -1.23 
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Conservative Cut Score 
     
   IOP-29 FDS ≥ .65 1 0.7 
 
125 82.8 b 
   IOP-29 FDS < .65 150 99.3 a 
 
26 17.2 
Standard Cut Score             
     
   IOP-29 FDS ≥ .50 5 3.3 
 
139 92.1 b 
   IOP-29 FDS < .50 146 96.7 a 
 
12 7.9 
Liberal Cut Score 
     
   IOP-29 FDS ≥ .30 17 11.3 
 
150 99.3 b 
   IOP-29 FDS < .30 134 88.7 a 
 
1 0.7 
Very Liberal Cut Score 
     
   IOP-29 FDS ≥ .15 43 28.5 
 
151 100.0 b 
   IOP-29 FDS < .15 108 71.5 a 
 
0 0.0 
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Table 5. Sensitivity and specificity of the IOP-29 RRS. 
  HON   SIM   HON & SIM   RND 
  n %   n %   n %   n % 






126 83.4 b 
IOP-29 RRS < 61 146 96.7 a   127 84.1 a   259 90.4 a   25 16.6 
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Figure 3. IOP-29 RRSD Scores by Condition 
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Now you will be asked to fake schizophrenia.  To help you assume the role of a person 
with schizophrenia, please read the following short story and link to NHS website. You will 
be asked to respond to questions as if you are the main character.  
  
Please read the story and link carefully. You cannot return to this page. 
 
Recently, you've fallen on hard times. Your long-time partner who you hoped to marry dumped 
you last week. You have not been performing well at work and you're nervous about your 
upcoming performance review. Your boss has noticed your poor performance and has hinted at 
the possibility of letting go of some employees. You have student loans to pay off and extra rent 
to pay now that your partner has moved out. On top of all of this, you hate your co-workers and 
your job. The situation is causing you immense stress. 
 
Two years ago, your partner encouraged you to see a psychologist because you seemed unhappy 
all the time. You went for a couple of visits. After sharing your childhood history and current 
problems, the psychologist diagnosed you with depression. The psychologist recommended 
Cognitive Behavioural Therapy and talking to your GP about going on medication. This made 
you feel small and like she was not listening to you. You refused to see the psychologist any 
longer because you disagreed with the diagnosis. At the time, you felt your problems were 
attributed to your partner’s lack of support and being unemployed. 
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To calm your nerves, you use marijuana recreationally. After work, you went to a friend’s house 
and smoked so much weed that for ten minutes, you thought you heard the devil inside your 
heart whispering to you. After you sober up, you remember all your problems that you are 
currently facing and you feel powerless. Then, out of nowhere, you think back to the time you 
saw the psychologist. You remember very clearly that when you shared your family history, the 
psychologist mentioned that you may be at risk of developing a psychotic disorder. At the time, 
you disagreed, as you know you are not “crazy” like your Aunt Suzie. You affirm to yourself 
that this strange incident was due to your marijuana use. 
 
You go home and search the internet for symptoms of psychotic disorders just to make sure you 
aren’t crazy. While you’re doing this, you realise that one psychotic disorder – schizophrenia, is 
a condition that deems you eligible for disability benefits, such as Employment and Support 
Allowance, and possible protection from losing your job. You decide a schizophrenia diagnosis 
may be the answer to all your problems. You learn about the symptoms of schizophrenia on 
the NHS website. Take a few minutes to read the page of schizophrenia symptoms 
(remember, the top 3 fakers win £20 each!). 
  
 
 
 
 
 
